Cargando...
Acute myeloid leukemia targets for bispecific antibodies
Despite substantial gains in our understanding of the genomics of acute myelogenous leukemia (AML), patient survival remains unsatisfactory especially among the older age group. T cell-based therapy of lymphoblastic leukemia is rapidly advancing; however, its application in AML is still lagging behi...
Gardado en:
| Publicado en: | Blood Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386336/ https://ncbi.nlm.nih.gov/pubmed/28157217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|